Yestar International Holdings Company Limited Board informed the Shareholders and the potential investors that, based on the preliminary review and assessment of the unaudited management accounts of the Group for the year ended 31 December 2015, the Group is expected to record an increase of not less than 80% and 40% in its consolidated net profit of the Group and consolidated net profit attributable to the owners of the parent, respectively, for the year ended 31 December 2015 as compared with that of the year ended 31 December 2014. The substantial increase is mainly attributable to (1) the outstanding performance of In Vitro Diagnostic business with high profit margin; and (2) stable contribution from its imaging products segment.
Yestar Healthcare Holdings Company Limited
Equities
2393
KYG9843W1125
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.049 HKD | +2.08% | -3.92% | +8.89% |
May. 07 | Yestar Healthcare Holdings Company Limited Announces Change of Principal Place of Business | CI |
Apr. 26 | Yestar Healthcare Narrows Loss in 2023 | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.89% | 14.33M | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- 2393 Stock
- News Yestar Healthcare Holdings Company Limited
- Yestar International Holdings Company Limited Provides Earnings Guidance for the Year Ended December 31, 2015